Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | ALB | P02768 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 7/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410425 | 1.00 | CA9 (0.43) | CA9ALBCA1CA2CA12 | |
| SCHEMBL20515160 | 1.00 | CA9 (0.43) | CA9ALBCA1CA2CA12 | |
| SCHEMBL29410424 | 1.00 | CA9 (0.43) | CA9ALBCA1CA2CA12 | |
| SCHEMBL18291960 | 0.95 | CA9 (0.42) | CA9ALBCA1CA2CA12 | |
| SCHEMBL18291963 | 0.94 | CA9 (0.42) | CA9ALBCA1CA2CA12 | |
| SCHEMBL18291997 | 0.94 | CA9 (0.42) | CA9ALBCA1CA2CA12 | |
| SCHEMBL18291987 | 0.93 | CA9 (0.41) | CA9ALBCA1CA2CA12 | |
| SCHEMBL18291989 | 0.93 | CA9 (0.41) | CA9ALBCA1CA2CA12 | |
| SCHEMBL18281367 | 0.93 | CA9 (0.39) | CA9ALBCA1CA2CA12 | |
| SCHEMBL18291996 | 0.93 | CA9 (0.47) | CA9ALBCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180280523-A1 | Small Molecule Drug Conjugates | ETH-ZURICH (CH) | 2018-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180280523-A1 | Small Molecule Drug Conjugates | CA9, CA12, CA2 | CA9 1/4885ALB 2274/4885CA1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.